Loading...

APC anti-mouse CD8a Antibody APC anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APC_041106
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • 53-6dot7_APC_041106
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100711 25 µg DKK197
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100712 100 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  2. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  3. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  4. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  5. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  6. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  7. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  8. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  9. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  10. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  11. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  12. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  13. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  14. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  15. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  16. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  17. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  18. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  19. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  20. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  21. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  22. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  23. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  24. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  25. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  26. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  27. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  28. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  29. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  30. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  31. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  32. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  33. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  34. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  35. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  36. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  37. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  38. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  39. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  40. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  41. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  42. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  43. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  44. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  45. Guo A, et al. 2022. Nature. 607:135. PubMed
  46. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  47. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  48. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  49. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  50. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  51. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  52. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  53. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  54. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  55. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  56. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  57. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  58. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  59. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  60. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  61. He Y, et al. 2023. Biomolecules. 13:. PubMed
  62. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  63. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  64. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  65. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  66. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  67. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  68. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  69. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  70. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  71. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  72. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  73. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  74. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  75. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  76. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  77. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  78. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  79. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  80. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  81. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  82. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  83. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  84. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  85. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  86. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  87. Dong L, et al. 2021. Cancer Cell. . PubMed
  88. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  89. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  90. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  91. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  92. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  93. Wang D, et al. 2018. Immunity. 48:659. PubMed
  94. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  95. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  96. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  97. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  98. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  99. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  100. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  101. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  102. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  103. Li ZX, et al. 2022. Arch Virol. :. PubMed
  104. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  105. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  106. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  107. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  108. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  109. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  110. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  111. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  112. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  113. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  114. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  115. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  116. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  117. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  118. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  119. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  120. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  121. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  122. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  123. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  124. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  125. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  126. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  127. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  128. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  129. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  130. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  131. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  132. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  133. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  134. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  135. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  136. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  137. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  138. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  139. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  140. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  141. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  142. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  143. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  144. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  145. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  146. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  147. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  148. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  149. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  150. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  151. Solanki A, et al. 2018. Development. 145. PubMed
  152. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  153. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  154. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  155. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  156. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  157. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  158. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  159. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  160. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  161. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  162. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  163. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  164. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  165. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  166. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  167. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  168. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  169. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  170. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  171. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  172. He X, et al. 2021. Small. 17:e2007165. PubMed
  173. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  174. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  175. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  176. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  177. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  178. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  179. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  180. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  181. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  182. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  183. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  184. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  185. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  186. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  187. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  188. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  189. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  190. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  191. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  192. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  193. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  194. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  195. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  196. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  197. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  198. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  199. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  200. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  201. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  202. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  203. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  204. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  205. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  206. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  207. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  208. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  209. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  210. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  211. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  212. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  213. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  214. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  215. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  216. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  217. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  218. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  219. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  220. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  221. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  222. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  223. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  224. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  225. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  226. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  227. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  228. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  229. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  230. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  231. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  232. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  233. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  234. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  235. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  236. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  237. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  238. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  239. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  240. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  241. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  242. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  243. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  244. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  245. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  246. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  247. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  248. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  249. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  250. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  251. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  252. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  253. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  254. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  255. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  256. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  257. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  258. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  259. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  260. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  261. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  262. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  263. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  264. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  265. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  266. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  267. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  268. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  269. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  270. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  271. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  272. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  273. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  274. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  275. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  276. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  277. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  278. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  279. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  280. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  281. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  282. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  283. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  284. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  285. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  286. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  287. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  288. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  289. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  290. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  291. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  292. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  293. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  294. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  295. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  296. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  297. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  298. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  299. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  300. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  301. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  302. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  303. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  304. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  305. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  306. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  307. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  308. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  309. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  310. Chen B, et al. 2021. Cell. 184:6262. PubMed
  311. Smith LK, et al. 2021. Elife. 10:. PubMed
  312. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  313. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  314. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  315. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  316. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  317. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  318. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  319. Zheng Y, et al. 2022. Transl Res. :. PubMed
  320. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  321. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  322. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  323. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  324. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  325. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  326. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  327. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  328. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  329. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  330. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  331. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  332. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  333. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  334. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  335. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  336. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  337. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  338. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  339. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  340. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  341. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  342. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  343. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  344. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  345. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  346. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  347. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  348. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  349. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  350. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  351. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  352. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  353. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  354. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  355. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  356. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  357. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  358. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  359. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  360. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  361. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  362. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  363. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  364. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  365. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  366. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  367. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  368. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  369. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  370. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  371. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  372. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  373. Guo A, et al. 2022. Nature. 607:135. PubMed
  374. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  375. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  376. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  377. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  378. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  379. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  380. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  381. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  382. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  383. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  384. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  385. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  386. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  387. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  388. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  389. He Y, et al. 2023. Biomolecules. 13:. PubMed
  390. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  391. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  392. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  393. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  394. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  395. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  396. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  397. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  398. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  399. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  400. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  401. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  402. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  403. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  404. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  405. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  406. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  407. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  408. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  409. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  410. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  411. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  412. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  413. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  414. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  415. Dong L, et al. 2021. Cancer Cell. . PubMed
  416. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  417. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  418. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  419. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  420. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  421. Wang D, et al. 2018. Immunity. 48:659. PubMed
  422. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  423. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  424. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  425. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  426. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  427. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  428. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  429. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  430. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  431. Li ZX, et al. 2022. Arch Virol. :. PubMed
  432. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  433. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  434. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  435. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  436. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  437. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  438. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  439. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  440. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  441. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  442. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  443. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  444. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  445. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  446. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  447. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  448. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  449. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  450. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  451. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  452. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  453. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  454. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  455. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  456. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  457. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  458. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  459. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  460. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  461. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  462. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  463. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  464. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  465. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  466. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  467. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  468. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  469. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  470. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  471. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  472. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  473. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  474. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  475. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  476. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  477. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  478. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  479. Solanki A, et al. 2018. Development. 145. PubMed
  480. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  481. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  482. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  483. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  484. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  485. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  486. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  487. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  488. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  489. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  490. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  491. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  492. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  493. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  494. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  495. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  496. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  497. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  498. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  499. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  500. He X, et al. 2021. Small. 17:e2007165. PubMed
  501. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  502. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  503. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  504. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  505. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  506. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  507. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  508. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  509. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  510. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  511. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  512. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  513. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  514. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  515. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  516. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  517. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  518. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  519. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  520. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  521. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  522. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  523. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  524. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  525. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  526. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  527. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  528. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  529. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  530. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  531. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  532. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  533. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  534. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  535. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  536. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  537. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  538. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  539. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  540. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  541. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  542. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  543. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  544. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  545. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  546. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  547. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  548. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  549. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  550. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  551. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  552. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  553. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  554. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  555. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  556. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  557. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  558. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  559. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  560. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  561. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  562. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  563. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  564. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  565. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  566. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  567. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  568. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  569. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  570. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  571. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  572. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  573. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  574. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  575. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  576. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  577. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  578. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  579. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  580. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  581. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  582. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  583. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  584. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  585. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  586. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  587. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  588. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  589. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  590. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  591. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  592. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  593. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  594. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  595. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  596. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  597. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  598. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  599. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  600. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  601. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  602. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  603. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  604. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  605. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  606. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  607. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  608. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  609. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  610. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  611. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  612. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  613. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  614. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  615. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  616. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  617. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  618. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  619. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  620. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  621. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  622. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  623. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  624. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  625. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  626. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  627. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  628. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  629. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  630. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  631. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  632. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  633. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  634. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  635. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  636. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  637. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  638. Chen B, et al. 2021. Cell. 184:6262. PubMed
  639. Smith LK, et al. 2021. Elife. 10:. PubMed
  640. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  641. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  642. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  643. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  644. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  645. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  646. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  647. Zheng Y, et al. 2022. Transl Res. :. PubMed
  648. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  649. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  650. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  651. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  652. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  653. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  654. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  655. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  656. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
RRID
AB_312750 (BioLegend Cat. No. 100711)
AB_312751 (BioLegend Cat. No. 100712)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
FITC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
APC anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APC_041106
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • 53-6dot7_APC_041106
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100711 25 µg DKK197
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100712 100 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  2. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  3. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  4. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  5. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  6. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  7. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  8. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  9. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  10. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  11. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  12. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  13. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  14. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  15. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  16. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  17. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  18. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  19. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  20. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  21. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  22. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  23. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  24. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  25. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  26. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  27. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  28. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  29. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  30. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  31. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  32. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  33. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  34. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  35. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  36. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  37. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  38. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  39. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  40. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  41. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  42. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  43. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  44. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  45. Guo A, et al. 2022. Nature. 607:135. PubMed
  46. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  47. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  48. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  49. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  50. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  51. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  52. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  53. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  54. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  55. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  56. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  57. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  58. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  59. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  60. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  61. He Y, et al. 2023. Biomolecules. 13:. PubMed
  62. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  63. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  64. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  65. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  66. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  67. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  68. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  69. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  70. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  71. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  72. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  73. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  74. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  75. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  76. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  77. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  78. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  79. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  80. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  81. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  82. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  83. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  84. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  85. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  86. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  87. Dong L, et al. 2021. Cancer Cell. . PubMed
  88. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  89. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  90. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  91. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  92. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  93. Wang D, et al. 2018. Immunity. 48:659. PubMed
  94. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  95. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  96. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  97. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  98. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  99. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  100. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  101. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  102. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  103. Li ZX, et al. 2022. Arch Virol. :. PubMed
  104. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  105. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  106. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  107. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  108. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  109. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  110. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  111. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  112. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  113. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  114. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  115. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  116. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  117. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  118. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  119. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  120. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  121. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  122. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  123. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  124. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  125. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  126. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  127. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  128. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  129. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  130. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  131. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  132. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  133. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  134. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  135. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  136. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  137. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  138. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  139. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  140. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  141. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  142. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  143. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  144. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  145. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  146. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  147. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  148. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  149. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  150. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  151. Solanki A, et al. 2018. Development. 145. PubMed
  152. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  153. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  154. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  155. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  156. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  157. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  158. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  159. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  160. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  161. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  162. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  163. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  164. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  165. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  166. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  167. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  168. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  169. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  170. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  171. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  172. He X, et al. 2021. Small. 17:e2007165. PubMed
  173. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  174. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  175. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  176. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  177. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  178. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  179. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  180. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  181. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  182. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  183. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  184. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  185. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  186. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  187. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  188. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  189. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  190. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  191. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  192. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  193. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  194. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  195. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  196. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  197. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  198. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  199. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  200. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  201. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  202. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  203. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  204. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  205. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  206. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  207. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  208. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  209. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  210. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  211. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  212. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  213. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  214. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  215. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  216. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  217. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  218. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  219. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  220. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  221. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  222. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  223. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  224. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  225. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  226. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  227. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  228. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  229. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  230. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  231. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  232. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  233. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  234. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  235. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  236. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  237. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  238. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  239. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  240. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  241. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  242. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  243. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  244. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  245. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  246. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  247. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  248. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  249. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  250. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  251. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  252. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  253. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  254. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  255. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  256. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  257. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  258. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  259. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  260. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  261. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  262. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  263. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  264. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  265. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  266. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  267. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  268. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  269. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  270. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  271. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  272. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  273. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  274. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  275. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  276. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  277. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  278. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  279. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  280. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  281. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  282. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  283. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  284. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  285. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  286. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  287. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  288. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  289. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  290. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  291. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  292. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  293. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  294. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  295. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  296. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  297. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  298. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  299. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  300. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  301. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  302. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  303. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  304. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  305. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  306. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  307. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  308. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  309. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  310. Chen B, et al. 2021. Cell. 184:6262. PubMed
  311. Smith LK, et al. 2021. Elife. 10:. PubMed
  312. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  313. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  314. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  315. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  316. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  317. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  318. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  319. Zheng Y, et al. 2022. Transl Res. :. PubMed
  320. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  321. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  322. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  323. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  324. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  325. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  326. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  327. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  328. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  329. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  330. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  331. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  332. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  333. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  334. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  335. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  336. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  337. Li X et al. 2019. Immunity. 50(3):576-590 . PubMed
  338. O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed
  339. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  340. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  341. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  342. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  343. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  344. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  345. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  346. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  347. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  348. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  349. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  350. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  351. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  352. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  353. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  354. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  355. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  356. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  357. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  358. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  359. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  360. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  361. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  362. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  363. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  364. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  365. Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed
  366. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  367. Zheng J, et al. 2023. Biomater Res. 27:9. PubMed
  368. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  369. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  370. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  371. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  372. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  373. Guo A, et al. 2022. Nature. 607:135. PubMed
  374. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  375. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  376. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  377. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  378. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  379. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  380. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  381. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  382. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  383. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  384. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  385. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  386. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  387. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  388. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  389. He Y, et al. 2023. Biomolecules. 13:. PubMed
  390. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  391. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  392. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  393. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  394. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  395. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  396. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  397. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  398. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  399. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  400. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  401. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  402. Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed
  403. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  404. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  405. Bian L, et al. 2022. Front Immunol. 13:938598. PubMed
  406. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  407. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  408. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  409. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  410. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  411. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  412. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  413. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  414. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  415. Dong L, et al. 2021. Cancer Cell. . PubMed
  416. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  417. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  418. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  419. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  420. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  421. Wang D, et al. 2018. Immunity. 48:659. PubMed
  422. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  423. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  424. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  425. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
  426. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  427. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  428. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  429. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  430. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  431. Li ZX, et al. 2022. Arch Virol. :. PubMed
  432. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  433. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  434. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  435. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  436. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  437. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  438. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  439. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  440. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  441. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  442. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  443. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  444. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  445. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  446. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  447. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  448. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  449. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  450. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  451. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  452. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  453. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  454. Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed
  455. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  456. Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed
  457. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  458. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  459. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  460. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  461. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  462. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  463. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  464. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  465. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  466. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  467. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  468. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  469. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  470. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  471. Frey N, et al. 2022. Nat Commun. 13:1804. PubMed
  472. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  473. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  474. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  475. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  476. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  477. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  478. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  479. Solanki A, et al. 2018. Development. 145. PubMed
  480. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  481. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  482. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  483. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  484. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  485. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  486. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  487. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  488. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  489. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  490. Brummer G, et al. 2020. Oncogene. 39:2275. PubMed
  491. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  492. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  493. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  494. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  495. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  496. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  497. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  498. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  499. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  500. He X, et al. 2021. Small. 17:e2007165. PubMed
  501. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  502. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  503. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  504. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  505. Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed
  506. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  507. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  508. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  509. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  510. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  511. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  512. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  513. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  514. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  515. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  516. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  517. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  518. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  519. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  520. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  521. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  522. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  523. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  524. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  525. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  526. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  527. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  528. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  529. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  530. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  531. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  532. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  533. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  534. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  535. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  536. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  537. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  538. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  539. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  540. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  541. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  542. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  543. Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed
  544. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  545. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  546. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  547. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  548. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  549. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  550. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  551. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  552. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  553. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  554. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  555. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  556. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  557. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  558. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  559. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  560. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  561. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  562. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  563. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  564. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  565. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  566. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  567. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  568. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  569. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  570. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  571. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  572. Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed
  573. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  574. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  575. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  576. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  577. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
  578. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  579. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  580. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  581. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  582. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  583. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  584. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  585. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  586. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  587. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  588. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  589. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  590. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  591. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  592. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  593. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  594. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  595. Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed
  596. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  597. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  598. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  599. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  600. Huber MK, et al. 2021. J Vis Exp. :. PubMed
  601. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  602. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  603. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  604. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  605. Li X, et al. 2017. Front Immunol. 8:1186. PubMed
  606. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  607. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  608. Fonderflick L, et al. 2022. Cells. 11:. PubMed
  609. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  610. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  611. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  612. Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed
  613. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  614. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  615. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  616. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  617. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  618. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  619. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  620. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  621. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  622. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  623. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  624. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  625. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  626. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  627. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  628. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  629. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  630. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  631. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  632. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  633. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  634. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  635. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  636. Liu YW, et al. 2022. JCI Insight. 7:. PubMed
  637. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  638. Chen B, et al. 2021. Cell. 184:6262. PubMed
  639. Smith LK, et al. 2021. Elife. 10:. PubMed
  640. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  641. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  642. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  643. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  644. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  645. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  646. Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
  647. Zheng Y, et al. 2022. Transl Res. :. PubMed
  648. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  649. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  650. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  651. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  652. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  653. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  654. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  655. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  656. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
RRID
AB_312750 (BioLegend Cat. No. 100711)
AB_312751 (BioLegend Cat. No. 100712)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
FITC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
APC anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account